ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs. - Wikidata - wikimedia - TriplyDB

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

http://www.wikidata.org/entity/Q37575649

about

P-Glycoprotein Transport of Neurotoxic Pesticides Pathways for small molecule delivery to the central nervous system across the blood-brain barrier.Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson's Disease.PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis.Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.Membrane Transporters and Pharmacological Implications Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior.ABCB1: is there a role in the drug treatment of Parkinson's disease?

P2860

Q28389145-04E78FD2-7CE6-46F2-81D7-73C6BCBC10DA Q33783748-E28F8820-9485-4E90-95CF-144D6481965F Q33900889-6D6C24D0-51CA-4228-8E5E-7305A94E1CA4 Q34392867-10A9C4D5-902F-4D1F-8C8A-82128935468D Q36953090-66A68B4C-627E-477A-B617-CA5F03A39B17 Q37328854-A7A68F20-C3AD-489A-AE7D-68B96F6E380C Q37550693-03D36CDD-EB0B-4CEB-A767-3CEAA105A91C Q37875183-B96723C0-16FD-4424-9CD5-4BA792F39DC9 Q38166961-36B4DCBC-7C5A-49EF-83E9-2C2CAEFFBEE0 Q41022921-A541B965-1790-4151-9C89-198199B57B0D Q46365946-B087792F-4176-4996-849C-23BEE4200669 Q49968346-964909CD-E086-47D9-AEDD-D6CFA603F23A

P2860

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

http://www.wikidata.org/entity/Q37575649

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@en

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@nl

type

label

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@en

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@nl

prefLabel

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@en

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@nl

P1433

Q37575649-7AC95D5E-8020-4383-8CFC-E7C1F9ED7551

P1476

Q37575649-7B3A9E81-ACBF-47E1-B710-EA3142022FAA

P2093

Q37575649-4E92C533-C8E7-417F-9A80-E690BD65474C

Q37575649-63A9E1A7-B9D3-4E17-B5DF-48A0DC29CDDD

P2860

Q37575649-009A0F40-778A-4F51-AF3D-391BB2166081

Q37575649-029BAD67-D4EF-4092-883F-B9E7D9DE3327

Q37575649-05269A0D-3624-4D08-85D4-715EB49A544F

Q37575649-10D1370F-79CB-4074-8F51-3BC112CAE913

Q37575649-1117316E-20B3-443E-96B2-F70251F60F42

Q37575649-183CFB3A-0F31-400F-92BE-23DBE345C182

Q37575649-1A488E60-86D1-47D3-B953-BADB558CDBEE

Q37575649-1D8D1877-577E-4D44-BF5C-0C2A05F915D8

Q37575649-1F1CDC16-3419-480B-8AE7-7EE6173509BA

Q37575649-22F8C289-D371-46B5-BDBC-1AE3E10BD064

P304

Q37575649-A2E33F80-964A-4E0D-915E-B697E01A4800

P31

Q37575649-C433D26C-DB21-4924-9CA6-CD7ACA837C53

P356

Q37575649-4C864A93-FBE5-46CD-A9A9-5542FB4CAC67

P407

Q37575649-7B9EAC37-86DB-499F-9B24-DD38F0835D76

P433

Q37575649-1DE51341-02FE-4AE5-8DEB-44C73A7D6648

P478

Q37575649-2EBC9170-3F1E-4C16-9B01-3A071F856788

P577

Q37575649-9930A047-D456-43AB-B9B2-8AE1C9B51121

P698

Q37575649-E83DA978-9526-4273-B158-0A4449EE7259

P356

17425250903193079

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.

@en

P2093

Christine Fernandez

http://www.w3.org/2001/XMLSchema#string

Sarah Vautier

http://www.w3.org/2001/XMLSchema#string

P2860

Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

beta-Amyloid efflux mediated by p-glycoprotein.

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Toxin-induced models of Parkinson's disease.

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

Sleep attacks in patients taking dopamine agonists: review

The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

P304

1349-1358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425250903193079

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19663741

http://www.w3.org/2001/XMLSchema#string